1. ASH 2011: “Real generosity toward the future lies in giving all to the present”

   • Michael Steurer

   editorial 13 September 2012 Pages: 167 - 168

2. News from the Neuro-Oncology front

   • Silvia Hofer
   • Christine Marosi

   editorial 20 July 2012 Pages: 169 - 170

3. ASH 2011—Hodgkin’s disease and the high grade lymphomas

   • Wolfgang Willenbacher
   • Ella Willenbacher

   special report 21 June 2012 Pages: 171 - 173

   

4. Treating T-cell lymphoma: is there a light at the end of the tunnel?

   • Georg Hopfinger
   • Olaf Merkel
   • Richard Greil

   short review 18 August 2012 Pages: 174 - 177

5. ASH update 2011: chronic lymphocytic leukemia and indolent lymphoma

   • Michael Steurer

   short review 12 September 2012 Pages: 178 - 181

   

6. Brief update on recent developments in CML

   • Stefan Schmidt

   short review 07 July 2012 Pages: 182 - 185

7. New developments in MDS

   • Michael Pfeilstöcker
   • Reinhard Stauder

   short review 13 July 2012 Pages: 186 - 189

8. ASH 2011—current developments in AML

   • Johannes Clausen

   short review 09 June 2012 Pages: 190 - 192

9. Primary central nervous system lymphoma: update and current approach

   • Lauren E. Abrey

   short review 18 September 2012 Pages: 193 - 196

10. Paraneoplastic neurologic disorders: a brief overview

    • Myrna R. Rosenfeld
    • Josep Dalmau

    short review 06 July 2012 Pages: 197 - 200

11. Clinically useful biomarkers in neurooncology

    • Matthias Preusser

    short review 21 June 2012 Pages: 201 - 204

    

12. Carcinomatous meningitis

    • Marc C. Chamberlain

    short review 18 August 2012 Pages: 205 - 209

    

13. Advanced neuroimaging techniques for diagnosis and treatment evaluation in neuro-oncology

    • Bernhard Schuknecht
    • Krisztina Baráth
    • Silvia Hofer

    short review 11 September 2012 Pages: 210 - 217

    

14. Drug therapy for recurrent, progressive, atypical, and malignant meningiomas

    • Christine Marosi

    short review 26 May 2012 Pages: 218 - 222

15. Current treatment of low grade gliomas

    • Martin J. van den Bent
    • Tom J. Snijders
    • Jacoline E. C. Bromberg

    review Open access 05 June 2012 Pages: 223 - 227

16. Update on molecular and genetic alterations in adult medulloblastoma

    • Marcel Kool
    • Andrey Korshunov
    • Stefan M. Pfister

    short review Open access 20 July 2012 Pages: 228 - 232

    

17. The End-of-Life in patients with glioma and their families

    • Christine Marosi
    • Birgit Flechl
    • Stefan Oberndorfer

    short review 14 September 2012 Pages: 233 - 235

18. New drugs for head and neck cancer

    • József Dudás
    • Heinz Zwierzina
    • Georg Mathias Sprinzl

    short review 22 August 2012 Pages: 236 - 241

    

19. Follow-up care for head and neck cancer patients

    • Markus Hambek

    short review 09 June 2012 Pages: 242 - 245

20. Sorafenib in thyroid cancer—a retrospective case series

    • Gabriele Gamerith
    • Andreas Pircher
    • Wolfgang Hilbe

    case report 14 July 2012 Pages: 246 - 249